249 related articles for article (PubMed ID: 33390788)
1. Inhibition of human amylin aggregation by Flavonoid Chrysin: An
Alkahtane AA; Alghamdi HA; Almutairi B; Khan MM; Hasnain MS; Abdel-Daim MM; Alghamdi WM; Alkahtani S
Int J Med Sci; 2021; 18(1):199-206. PubMed ID: 33390788
[TBL] [Abstract][Full Text] [Related]
2. Protein aggregates and proteostasis in aging: Amylin and β-cell function.
Press M; Jung T; König J; Grune T; Höhn A
Mech Ageing Dev; 2019 Jan; 177():46-54. PubMed ID: 29580826
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid.
Azzam SK; Jang H; Choi MC; Alsafar H; Lukman S; Lee S
Mol Pharm; 2018 Jun; 15(6):2098-2106. PubMed ID: 29709194
[TBL] [Abstract][Full Text] [Related]
4. Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation.
López LC; Varea O; Navarro S; Carrodeguas JA; Sanchez de Groot N; Ventura S; Sancho J
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322259
[TBL] [Abstract][Full Text] [Related]
5. Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
Aitken JF; Loomes KM; Riba-Garcia I; Unwin RD; Prijic G; Phillips AS; Phillips ARJ; Wu D; Poppitt SD; Ding K; Barran PE; Dowsey AW; Cooper GJS
Biochem Biophys Res Commun; 2017 Jan; 482(4):625-631. PubMed ID: 27865831
[TBL] [Abstract][Full Text] [Related]
6. Amylin and beta amyloid proteins interact to form amorphous heterocomplexes with enhanced toxicity in neuronal cells.
Bharadwaj P; Solomon T; Sahoo BR; Ignasiak K; Gaskin S; Rowles J; Verdile G; Howard MJ; Bond CS; Ramamoorthy A; Martins RN; Newsholme P
Sci Rep; 2020 Jun; 10(1):10356. PubMed ID: 32587390
[TBL] [Abstract][Full Text] [Related]
7. Intraneuronal Amylin Deposition, Peroxidative Membrane Injury and Increased IL-1β Synthesis in Brains of Alzheimer's Disease Patients with Type-2 Diabetes and in Diabetic HIP Rats.
Verma N; Ly H; Liu M; Chen J; Zhu H; Chow M; Hersh LB; Despa F
J Alzheimers Dis; 2016 May; 53(1):259-72. PubMed ID: 27163815
[TBL] [Abstract][Full Text] [Related]
8. The toxic nature of murine amylin and the immune responsivity of pancreatic islet to conformational antibody in mice.
Erthal LCS; Jotha-Mattos L; Lara FA; Dos Reis SA; de Oliveira Pascarelli BM; Costa CM; Souza KLA; Lima LMTR
Mol Cell Biochem; 2018 Oct; 447(1-2):1-7. PubMed ID: 29372531
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives.
Bahramikia S; Yazdanparast R
Eur J Pharmacol; 2013 May; 707(1-3):17-25. PubMed ID: 23528352
[TBL] [Abstract][Full Text] [Related]
10. Human Amylin: From Pathology to Physiology and Pharmacology.
Ling W; Huang YM; Qiao YC; Zhang XX; Zhao HL
Curr Protein Pept Sci; 2019; 20(9):944-957. PubMed ID: 30919775
[TBL] [Abstract][Full Text] [Related]
11. Assay development and multivariate scoring for high-content discovery of chemoprotectants of endoplasmic-reticulum-stress-mediated amylin-induced cytotoxicity in pancreatic beta cells.
Law CJ; Ashcroft HA; Zheng W; Sexton JZ
Assay Drug Dev Technol; 2014 Sep; 12(7):375-84. PubMed ID: 25181410
[TBL] [Abstract][Full Text] [Related]
12. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol.
Trikha S; Jeremic AM
J Biol Chem; 2011 Oct; 286(41):36086-36097. PubMed ID: 21865171
[TBL] [Abstract][Full Text] [Related]
13. Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment.
Corrigan RR; Piontkivska H; Casadesus G
Curr Neuropharmacol; 2022; 20(10):1894-1907. PubMed ID: 34852745
[TBL] [Abstract][Full Text] [Related]
14. Amylin uncovered: a review on the polypeptide responsible for type II diabetes.
Pillay K; Govender P
Biomed Res Int; 2013; 2013():826706. PubMed ID: 23607096
[TBL] [Abstract][Full Text] [Related]
15. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
[TBL] [Abstract][Full Text] [Related]
16. Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes.
Ly H; Despa F
Expert Rev Proteomics; 2015; 12(6):575-7. PubMed ID: 26503000
[TBL] [Abstract][Full Text] [Related]
17. Human IAPP amyloidogenic properties and pancreatic β-cell death.
Fernández MS
Cell Calcium; 2014 Nov; 56(5):416-27. PubMed ID: 25224501
[TBL] [Abstract][Full Text] [Related]
18. Azadirachtin inhibits amyloid formation, disaggregates pre-formed fibrils and protects pancreatic β-cells from human islet amyloid polypeptide/amylin-induced cytotoxicity.
Dubey R; Patil K; Dantu SC; Sardesai DM; Bhatia P; Malik N; Acharya JD; Sarkar S; Ghosh S; Chakrabarti R; Sharma S; Kumar A
Biochem J; 2019 Mar; 476(5):889-907. PubMed ID: 30814273
[TBL] [Abstract][Full Text] [Related]
19. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
[TBL] [Abstract][Full Text] [Related]
20. Common fibrillar spines of amyloid-β and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors.
Krotee P; Griner SL; Sawaya MR; Cascio D; Rodriguez JA; Shi D; Philipp S; Murray K; Saelices L; Lee J; Seidler P; Glabe CG; Jiang L; Gonen T; Eisenberg DS
J Biol Chem; 2018 Feb; 293(8):2888-2902. PubMed ID: 29282295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
